FN1 and neoplasm: Particularly human and animal blood isolates seem to have the ability to bind fibrinogen, while fibronectin-binding is variable, which implies different adhesion abilities regarding fibronectin in the tumor-microenvironment and fibrinogen at damaged sites requiring blood clotting.